During the past decade, Medizinische Klinik und Poliklinik III - Universitaetsklinikum Leipzig conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Medizinische Klinik und Poliklinik III - Universitaetsklinikum Leipzig" are "Lymphoma" (1 trials) and "Metastatic Cancer" (1 trials). Many other conditions were trialed in "Medizinische Klinik und Poliklinik III - Universitaetsklinikum Leipzig" in a lesser frequency.

Most popular intervention types in "Medizinische Klinik und Poliklinik III - Universitaetsklinikum Leipzig" are "Radiation" (2 trials), "Biological" (1 trials), "Drug" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (2 trials), "EPOCH regimen" (1 trials), "adjuvant therapy" (1 trials), "cyclophosphamide" (1 trials) and "doxorubicin hydrochloride" (1 trials). Other intervention names were less common.

The vast majority of trials in "Medizinische Klinik und Poliklinik III - Universitaetsklinikum Leipzig" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Medizinische Klinik und Poliklinik III - Universitaetsklinikum Leipzig". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Medizinische Klinik und Poliklinik III - Universitaetsklinikum Leipzig, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Medizinische Klinik und Poliklinik III - Universitaetsklinikum Leipzig, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".